KORU Medical Systems, Inc.
Key Metrics
- Previous Close
- $3.49
- 52-Week Range
- $2.86 – $6.61
- Market Cap
- $149.64M
- P/E (TTM)
- —
- EPS (TTM)
- -0.02
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 8.25
- PEG Ratio
- —
- Return on Equity
- -4.59%
- Return on Assets
- -1.29%
- Gross Margin
- 63.63%
- Operating Margin
- -1.24%
- Profit Margin
- -1.78%
- Current Ratio
- 2.96
- Debt/Equity
- 0.18
- Total Debt
- $3.50M
- Free Cash Flow
- $-1.05M
- Revenue Growth
- 11.20%
- Earnings Growth
- —
- Enterprise Value
- $145.78M
Market Snapshot
About
KORU Medical Systems develops and commercializes innovative and patient-centric subcutaneous drug delivery systems. The company's flagship product, the Freedom System, is a wearable infusion pump that enables patients to self-administer immunoglobulin therapy at home. KORU's technology improves patient quality of life by providing convenient alternatives to hospital-based infusion treatments.